RIA
ARIA

Regal Investment Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Regal Investment Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,000
Closed -$41K – 1060
2015
Q1 		$41K Hold
5,000
– – 0.01% 455
2014
Q4 		$34K Hold
5,000
– – 0.01% 451
2014
Q3 		$27K Hold
5,000
– – 0.01% 508
2014
Q2 		$32K Hold
5,000
– – 0.01% 461
2014
Q1 		$40K Hold
5,000
– – 0.02% 380
2013
Q4 		$34K Buy
+5,000
New +$27K 0.02% 355

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Regal Investment Advisors's ARIA Position: Q2 2015 in Review

Regal Investment Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 5,000 shares — an estimated $41K sold.

Regal Investment Advisors first reported a position in ARIA in Q4 2013 and held it in 6 quarters. The position peaked at $41K in Q1 2015. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • Regal Investment Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 5,000 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $41K.
  • Regal Investment Advisors first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Regal Investment Advisors's Ariad Pharmaceuticals Inc position peaked at $41K in Q1 2015.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Regal Investment Advisors's 13F filing for Q2 2015, filed 23 Jul 2015.